Fears For Ukraine’s Access To Medicines And Trials As Russian Invasion Continues
European Pharma Aims To Maintain Supply Chains
Executive Summary
The European pharma sector is looking to maintain supplies of essential medicines to Ukraine and Russia as invasion continues while a US biopharma group is calling for industry to boycott all non-food and medical trade with Russia.
You may also be interested in...
Biotech CEOs Take Assertive Stance On Ukraine War, While PhRMA Remains More Neutral
PhRMA wants to ensure medicines remain available, as many smaller companies and other stakeholders call for ‘disengagement’ from Russia.
Biotech CEOs Take Assertive Stance On Ukraine War, While PhRMA Remains More Neutral
PhRMA wants to ensure medicines remain available, as many smaller companies and other stakeholders call for ‘disengagement’ from Russia.
Encouraging Biomarker Data Lift UniQure’s Huntington’s Disease Hopes
Hopes rise as first four evaluable patients experienced no serious adverse events, and a sustained decline in level of key Huntington’s disease protein with the novel gene therapy product.